|
1
|
Davies H, Bignell GR, Cox C, Stephens P,
Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W,
et al: Mutations of the BRAF gene in human cancer. Nature.
417:949–954. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chapman PB, Hauschild A, Robert C, Haanen
JB, Ascierto P, Larkin J, Dummer R, Garbe C, Testori A, Maio M, et
al: Improved survival with vemurafenib in melanoma with BRAF V600E
mutation. N Engl J Med. 364:2507–2516. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hauschild A, Grob JJ, Demidov LV, Jouary
T, Gutzmer R, Millward M, Rutkowski P, Blank CU, Miller WH Jr,
Kaempgen E, et al: Dabrafenib in BRAF-mutated metastatic melanoma:
A multicentre, open-label, phase 3 randomised controlled trial.
Lancet. 380:358–365. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Robert C, Long GV, Brady B, Dutriaux C,
Maio M, Mortier L, Hassel JC, Rutkowski P, McNeil C,
Kalinka-Warzocha E, et al: Nivolumab in previously untreated
melanoma without BRAF mutation. N Engl J Med. 372:320–330. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hodi FS, O'Day SJ, McDermott DF, Weber RW,
Sosman JA, Haanen JB, Gonzalez R, Robert C, Schadendorf D, Hassel
JC, et al: Improved survival with ipilimumab in patients with
metastatic melanoma. N Engl J Med. 363:711–723. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kwon BS, Haq AK, Pomerantz SH and Halaban
R: Isolation and sequence of a cDNA clone for human tyrosinase the
maps at the mouse c-albino locus. Proc Natl Acad Sci USA.
84:7473–7477. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ujvari A, Aron R, Eisenhaure T, Cheng E,
Parag HA, Smicun Y, Halaban R and Hebert DN: Translation rate of
human tyrosinase determines its N-linked glycosylation level. J
Biol Chem. 276:5924–5931. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Slominski A, Zmijewski MA and Pawelek J:
L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators
of melanocyte functions. Pigment Cell Melanoma Res. 25:14–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herraiz C, Martínez-Vicente I and Maresca
V: The α-melanocyte-stimulating hormone/melanocortin-1 receptor
interaction: A driver of pleiotropic effects beyond pigmentation.
Pigment Cell Melanoma Res. 34:748–761. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Slominski A, Tobin DJ, Shibahara S and
Wortsman J: Melanin pigmentation in mammalian skin and its hormonal
regulation. Physiol Rev. 84:1155–1228. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Misra UK and Pizzo SV: Coordinate
regulation of forskolin-induced cellular proliferation in
macrophages by protein kinase A/cAMP-response element-binding
protein (CREB) and Epac1-Rap1 signaling: Effects of silencing CREB
gene expression on Akt activation. J Biol Chem. 280:38276–38289.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Price ER, Horstmann MA, Wells AG,
Weilbaecher KN, Takemoto CM, Landis MW and Fisher DE:
a-Melanocyte-stimulating hormone signaling regulates expression of
microphthalmia, a gene deficient in Waardenburg syndrome. J Biol
Chem. 273:33042–33047. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Garraway LA, Widlund HR, Rubin MA, Getz G,
Berger AJ, Ramaswamy S, Beroukhim R, Milner DA, Granter SR, Du J,
et al: Integrative genomic analyses identify MITF as a lineage
survival oncogene amplified in malignant melanoma. Nature.
436:117–122. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hendrix MJ, Seftor EA, Hess AR and Seftor
RE: Vasculogenic mimicry and tumour-cell plasticity: Lessons from
melanoma. Nat Rev Cancer. 3:411–421. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Takeuchi H, Kuo C, Morton DL, Wang HJ and
Hoon DS: Expression of differentiation melanoma-associated antigen
genes is associated with favorable disease outcome in
advanced-stage melanomas. Cancer Res. 63:441–448. 2003.PubMed/NCBI
|
|
16
|
Folberg R, Hendrix MJ and Maniotis AJ:
Vasculogenic mimicry and tumor angiogenesis. Am J Pathol.
156:361–381. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Maniotis AJ, Folberg R, Hess A, Seftor EA,
Gardner LM, Pe'er J, Trent JM, Meltzer PS and Hendrix MJ: Vascular
channel formation by human melanoma cells in vivo and in vitro:
Vasculogenic mimicry. Am J Pathol. 155:739–752. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shirakawa K, Tsuda H, Heike Y, Kato K,
Asada R, Inomata M, Sasaki H, Kasumi F, Yoshimoto M, Iwanaga T, et
al: Absence of endothelial cells, central necrosis, and fibrosis
are associated with aggressive inflammatory breast cancer. Cancer
Res. 61:445–451. 2001.PubMed/NCBI
|
|
19
|
Sood AK, Seftor EA, Fletcher MS, Gardner
LM, Heidger PM, Buller RE, Seftor RE and Hendrix MJ: Molecular
determinants of ovarian cancer plasticity. Am J Pathol.
158:1279–1288. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sharma N, Seftor RE, Seftor EA, Gruman LM,
Heidger PM Jr, Cohen MB, Lubaroff DM and Hendrix MJ: Prostatic
tumor cell plasticity involves cooperative interactions of distinct
phenotypic subpopulations: Role in vasculogenic mimicry. Prostate.
50:189–201. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Passalidou E, Trivella M, Singh N,
Ferguson M, Hu J, Cesario A, Granone P, Nicholson AG, Goldstraw P,
Ratcliffe C, et al: Vascular phenotype in angiogenic and
non-angiogenic lung non-small cell carcinomas. Br J Cancer.
86:244–249. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
van der Schaft DW, Hillen F, Pauwels P,
Kirschmann DA, Castermans K, Egbrink MG, Tran MG, Sciot R, Hauben
E, Hogendoorn PC, et al: Tumor cell plasticity in Ewing sarcoma, an
alternative circulatory system stimulated by hypoxia. Cancer Res.
65:11520–11528. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Seftor RE, Seftor EA, Koshikawa N, Meltzer
PS, Gardner LM, Bilban M, Stetler-Stevenson WG, Quaranta V and
Hendrix MJ: Cooperative interactions of laminin 5 g2 chain, matrix
metalloproteinase-2, and membrane type-1-matrix/metalloproteinase
are required for mimicry of embryonic vasculogenesis by aggressive
melanoma. Cancer Res. 61:6322–6327. 2001.PubMed/NCBI
|
|
24
|
Clarijs R, Otte-Höller I, Ruiter DJ and de
Waal RM: Presence of a fluid-conducting meshwork in xenografted
cutaneous and primary human uveal melanoma. Invest Ophthalmol Vis
Sci. 43:912–918. 2002.PubMed/NCBI
|
|
25
|
Mueller AJ, Maniotis AJ, Freeman WR,
Bartsch DU, Schaller UC, Bergeron-Lynn G, Cheng L, Taskintuna I,
Chen X, Kan-Mitchell J and Folberg R: An orthotopic model for human
uveal melanoma in SCID mice. Microvasc Res. 64:207–213. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Thies A, Mangold U, Moll I and Schumacher
U: PAS-positive loops and networks as a prognostic indicator in
cutaneous malignant melanoma. J Pathol. 195:537–542. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wei X, Chen Y, Jiang X, Peng M, Liu Y, Mo
Y, Ren D, Hua Y, Yu B, Zhou Y, et al: Mechanisms of vasculogenic
mimicry in hypoxic tumor microenvironments. Mol Cancer. 20:72021.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Delgado-Bellido D, Serrano-Saenz S,
Fernández-Cortés M and Oliver FJ: Vasculogenic mimicry signaling
revisited: Focus on non-vascular VE-cadherin. Mol Cancer.
16:652017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Schnegg CI, Yang MH, Ghosh SK and Hsu MY:
Induction of vasculogenic mimicry overrides VEGF-A silencing and
enriches stem-like cancer cells in melanoma. Cancer Res.
75:1682–1690. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Williamson SC, Metcalf RL, Trapani F,
Mohan S, Antonello J, Abbott B, Leong HS, Chester CP, Simms N,
Polanski R, et al: Vasculogenic mimicry in small cell lung cancer.
Nat Commun. 7:133222016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kawahara R, Niwa Y and Simizu S: Integrin
β1 is an essential factor in vasculogenic mimicry of human cancer
cells. Cancer Sci. 109:2490–2496. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ran FA, Hsu PD, Wright J, Agarwala V,
Scott DA and Zhang F: Genome engineering using the CRISPR-Cas9
system. Nat Protoc. 8:2281–2308. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hasegawa T: Tyrosinase-expressing neuronal
cell line as in vitro model of Parkinson's disease. Int J Mol Sci.
11:1082–1089. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Mizuta H, Kuga K, Suzuki T, Niwa Y, Dohmae
N and Simizu S: C-mannosylation of R-spondin2 activates
Wnt/β-catenin signaling and migration activity in human tumor
cells. Int J Oncol. 54:2127–2138. 2019.PubMed/NCBI
|
|
35
|
Tamura Y, Simizu S, Muroi M, Takagi S,
Kawatani M, Watanabe N and Osada H: Polo-like kinase 1
phosphorylates and regulates Bcl-xL during pironetin-induced
apoptosis. Oncogene. 28:107–116. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Akiu S, Suzuki Y, Asahara T, Fujinuma Y
and Fukuda M: Inhibitory effect of arbutin on
melanogenesis-biochemical study using cultured B16 melanoma cells.
Nihon Hifuka Gakkai Zasshi. 101:609–613. 1991.(In Japanese).
PubMed/NCBI
|
|
37
|
Opitz S, Käsmann-Kellner B, Kaufmann M,
Schwinger E and Zühlke C: Detection of 53 novel DNA variations
within the tyrosinase gene and accumulation of mutations in 17
patients with albinism. Hum Mutat. 23:630–631. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Halaban R, Svedine S, Cheng E, Smicun Y,
Aron R and Hebert DN: Endoplasmic reticulum retention is a common
defect associated with tyrosinase-negative albinism. Proc Natl Acad
Sci USA. 97:5889–5894. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Busca R and Ballotti R: Cyclic AMP a key
messenger in the regulation of skin pigmentation. Pigment Cell Res.
13:60–69. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Slominski A, Moellmann G and Kuklinska E:
L-tyrosine, L-dopa, and tyrosinase as positive regulators of the
subcellular apparatus of melanogenesis in Bomirski Ab amelanotic
melanoma cells. Pigment Cell Res. 2:109–116. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Slominski A and Paus R: Towards defining
receptors for L-tyrosine and L-dopa. Mol Cell Endocrinol.
99:C7–C11. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Slominski A, Kim TK, Brożyna AA,
Janjetovic Z, Brooks DL, Schwab LP, Skobowiat C, Jóźwicki W and
Seagroves TN: The role of melanogenesis in regulation of melanoma
behavior: Melanogenesis leads to stimulation of HIF-1a expression
and HIF-dependent attendant pathways. Arch Biochem Biophys.
563:79–93. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Slominski RM, Zmijewski MA and Slominski
AT: The role of melanin pigment in melanoma. Exp Dermatol.
24:258–259. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Slominski A, Paus R and Schadendorf D:
Melanocytes as ‘sensory’ and regulatory cells in the epidermis. J
Theor Biol. 164:103–120. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Slominski A: Neuroendocrine activity of
the melanocyte. Exp Dermatol. 18:760–763. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lissitzky JC, Parriaux D, Ristorcelli E,
Vérine A, Lombardo D and Verrando P: Cyclic AMP signaling as a
mediator of vasculogenic mimicry in aggressive human melanoma cells
in vitro. Cancer Res. 69:802–809. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang S, Zhang Z, Qian W, Ji D, Wang Q, Ji
B, Zhang Y, Zhang C and Sun Y, Zhu C and Sun Y: Angiogenesis and
vasculogenic mimicry are inhibited by 8-Br-cAMP through activation
of the cAMP/PKA pathway in colorectal cancer. Onco Targets Ther.
11:3765–3774. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Robbins PF, El-Gamil M, Kawakami Y,
Stevens E, Yannelli JR and Rosenberg SA: Recognition of tyrosinase
by tumor-infiltrating lymphocytes from a patient responding to
immunotherapy. Cancer Res. 54:3124–3126. 1994.PubMed/NCBI
|
|
49
|
Sanchez-Perez L, Kottke T, Diaz RM, Ahmed
A, Thompson J, Chong H, Melcher A, Holmen S, Daniels G and Vile RG:
Potent selection of antigen loss variants of B16 melanoma following
inflammatory killing of melanocytes in vivo. Cancer Res.
65:2009–2017. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Vavricka CJ, Christensen BM and Li J:
Melanization in living organisms: A perspective of species
evolution. Protein Cell. 1:830–841. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Brożyna AA, Jóźwicki W, Roszkowski K,
Filipiak J and Slominski AT: Melanin content in melanoma metastases
affects the outcome of radiotherapy. Oncotarget. 7:17844–17853.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Slominski A, Zbytek B and Slominski R:
Inhibitors of melanogenesis increase toxicity of cyclophosphamide
and lymphocytes against melanoma cells. Int J Cancer.
124:1470–1477. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Slominski A, Paus R and Mihm MC:
Inhibition of melanogenesis as an adjuvant strategy in the
treatment of melanotic melanomas: Selective review and hypothesis.
Anticancer Res. 18:3709–3715. 1998.PubMed/NCBI
|
|
54
|
Fürst K, Steder M, Logotheti S, Angerilli
A, Spitschak A, Marquardt S, Schumacher T, Engelmann D,
Herchenröder O, Rupp RAW and Pützer BM: DNp73-induced degradation
of tyrosinase links depigmentation with EMT-driven melanoma
progression. Cancer Lett. 442:299–309. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Tas F: Melanoma-associated
hypopigmentation in association with locoregional relapse of
melanoma depigmentation. Surgery. 150:1011–1012. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Bennett DC: Differentiation in mouse
melanoma cells: Initial reversibility and an on-off stochastic
model. Cell. 34:445–453. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Pinner S, Jordan P, Sharrock K, Bazley L,
Collinson L, Marais R, Bonvin E, Goding C and Sahai E: Intravital
imaging reveals transient changes in pigment production and Brn2
expression during metastatic melanoma dissemination. Cancer Res.
69:7969–7977. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Hearing VJ: Biochemical control of
melanogenesis and melanosomal organization. J Investig Dermatol
Symp Proc. 4:24–28. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Sekine Y, Togi S, Muromoto R, Kon S, Kitai
Y, Yoshimura A, Oritani K and Matsuda T: STAP-2 protein expression
in B16F10 melanoma cells positively regulates protein levels of
tyrosinase, which determines organs to infiltrate in the body. J
Biol Chem. 290:17462–17473. 2015. View Article : Google Scholar : PubMed/NCBI
|
